These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 21491451)

  • 21. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
    Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
    Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porous carrier based floating granular delivery system of repaglinide.
    Jain SK; Agrawal GP; Jain NK
    Drug Dev Ind Pharm; 2007 Apr; 33(4):381-91. PubMed ID: 17523003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
    Athawale RB; Jain DS; Singh KK; Gude RP
    Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
    Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
    Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoemulsion: for improved oral delivery of repaglinide.
    Akhtar J; Siddiqui HH; Fareed S; Badruddeen ; Khalid M; Aqil M
    Drug Deliv; 2016 Jul; 23(6):2026-34. PubMed ID: 27187792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
    Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
    Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of a controlled drug release of repaglinide through matrix pellets: in vitro and in vivo studies.
    Tavakoli N; Minaiyan M; Tabbakhian M; Pendar Y
    J Microencapsul; 2014; 31(6):529-34. PubMed ID: 24697183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
    Luo Y; Chen D; Ren L; Zhao X; Qin J
    J Control Release; 2006 Aug; 114(1):53-9. PubMed ID: 16828192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
    Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
    Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
    Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
    Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
    Nazief AM; Hassaan PS; Khalifa HM; Sokar MS; El-Kamel AH
    Int J Nanomedicine; 2020; 15():1129-1148. PubMed ID: 32110012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.